Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Main navigation

  • Foundations of Science

    • Understanding Conditions
      • Autoimmune Diseases
      • Cancer
      • Cardiovascular & Metabolism
      • Rare Diseases
      • Infectious Diseases

    • Biology Basics
      • Genetics
      • Immune System

    • Science in the Everyday
  • Advancing Medical Research

    • Innovations
      • Drug Discovery
      • Clinical Trials
      • Our Scientists
      • Technology

    • Focus Areas
      • Covid-19
      • Immunology
      • Oncology
      • Vaccines
      • Cardiovascular & Metabolism
  • podcasts

Header top

  • About

Social

  • Facebook
  • Twitter
  • YouTube
  • Rss feed

Main navigation

  • Foundations of Science

    • Understanding Conditions
      • Autoimmune Diseases
      • Cancer
      • Cardiovascular & Metabolism
      • Rare Diseases
      • Infectious Diseases

    • Biology Basics
      • Genetics
      • Immune System

    • Science in the Everyday
  • Advancing Medical Research

    • Innovations
      • Drug Discovery
      • Clinical Trials
      • Our Scientists
      • Technology

    • Focus Areas
      • Covid-19
      • Immunology
      • Oncology
      • Vaccines
      • Cardiovascular & Metabolism
  • podcasts
Podcasts

Get Science Podcast: When Biology Breaks the Rules

Get Science Podcast: When Biology Breaks the Rules

Get Science Podcast: When Biology Breaks the Rules

Since grade school, we’ve been taught that the laws of science are hard and fast. But as technology enables scientists to delve deeper and collaborate better, they’re increasingly encountering surprising pockets of science that defy these “rules.” In a special series of the Get Science Podcast, we’ll explore some of science’s unknowns with the scientists pushing the boundaries of biology and following the data to unexpected places.  

First up: Christine Bulawa, a Senior Director in Pfizer’s Rare Disease Research Unit, and Stefan McDonough, Executive Director, Head of Human Genetics at Pfizer. As part of Pfizer’s Innovative Target Exploration Network (ITEN), they’re working with academic researchers across the globe to deepen their understanding of repeat expansion disorders, which include Huntington’s disease and amyotrophic lateral sclerosis (ALS). Their research is uncovering many insights – all valuable, but some strikingly unanticipated. In this episode, Bulawa and McDonough help us explore the “rule-breaking science” behind repeat expansion disorders.  

Listen to some of the insights they’ve discovered. 

(Left to right) Guests Christine Bulawa and Stefan McDonough posing with Get Science Podcast host Molly MacLeod. 

 

Tags
Our Scientists
Innovation
Read More
Media Name: 200129_getscience_copy.png
Get Science Podcast: Sought After Skills in the Transition to Industry
Media Name: 200129_getscience_copy.png
Get Science Podcast: The Power of the Mentor-Postdoc Relationship
Media Name: 200129_getscience_copy.png
Get Science Podcast: The Next Generation of Scientists Learn the Ropes of the Industry
Media Name: season2_li_2.png
Get Science Podcast: Decoding the Complexity of the Immune System to Find Drivers of Disease
Show
Hide

Get the Latest Updates

pfizer logo

Footer menu

  • About
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Social

  • Facebook
  • Twitter
  • YouTube
  • Rss feed

Copyright © 2002-2020 Pfizer Inc. All rights reserved. This information-including product information-is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.